These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7019703

  • 1. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.
    Santen RJ, Worgul TJ, Samojlik E, Interrante A, Boucher AE, Lipton A, Harvey HA, White DS, Smart E, Cox C, Wells SA.
    N Engl J Med; 1981 Sep 03; 305(10):545-51. PubMed ID: 7019703
    [Abstract] [Full Text] [Related]

  • 2. [Chemical adrenalectomy induced by aminoglutethimide in the treatment of breast cancer. A review].
    Cikes M.
    Schweiz Med Wochenschr; 1983 Mar 19; 113(11):382-91. PubMed ID: 6342129
    [Abstract] [Full Text] [Related]

  • 3. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE, Bird CE, Mackie KW.
    Can J Surg; 1982 Nov 19; 25(6):695-7. PubMed ID: 7139430
    [Abstract] [Full Text] [Related]

  • 4. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
    Samojlik E, Veldhuis JD, Wells SA, Santen RJ.
    J Clin Invest; 1980 Mar 19; 65(3):602-12. PubMed ID: 6986409
    [Abstract] [Full Text] [Related]

  • 5. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
    Ingle JN, Green SJ, Ahmann DL, Edmonson JH, Nichols WC, Frytak S, Rubin J.
    Cancer Res; 1982 Aug 19; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
    [Abstract] [Full Text] [Related]

  • 6. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ, Worgul TJ, Samojlik E, Boucher AE, Lipton A, Harvey H.
    Cancer Res; 1982 Aug 19; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [Abstract] [Full Text] [Related]

  • 7. Comparison of surgical adrenalectomy to medical adrenalectomy in patients with metastatic carcinoma of the breast.
    Wells SA, Worgul TJ, Samojlik E, Boucher AE, Lipton A, Harvey H, White D, Smart E, Cox C, Santen RJ.
    Cancer Res; 1982 Aug 19; 42(8 Suppl):3454s-3457s. PubMed ID: 7044527
    [No Abstract] [Full Text] [Related]

  • 8. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
    Rose C, Kamby C, Mouridsen HT, Bastholt L, Brincker H, Skovgaard-Poulsen H, Andersen AP, Loft H, Dombernowsky P, Andersen KW.
    Breast Cancer Res Treat; 1986 Aug 19; 7 Suppl():S45-50. PubMed ID: 3527306
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
    Santen RJ, Boucher AE, Santner SJ, Henderson IC, Harvey H, Lipton A.
    J Lab Clin Med; 1987 Mar 19; 109(3):278-89. PubMed ID: 3546561
    [Abstract] [Full Text] [Related]

  • 10. [Low-dose aminoglutethimide (500 mg/day) and hydrocortisone (30 mg/day) in advanced cancer of breast].
    Bonneterre J, Pion JM, Demaille A.
    Bull Cancer; 1987 Mar 19; 74(3):241-7. PubMed ID: 3304478
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
    Smith IE, Harris AL, Morgan M, Gazet JC, McKinna JA.
    Cancer Res; 1982 Aug 19; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
    [Abstract] [Full Text] [Related]

  • 12. Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.
    Santen RJ.
    Breast Cancer Res Treat; 1981 Aug 19; 1(3):183-202. PubMed ID: 6293627
    [Abstract] [Full Text] [Related]

  • 13. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH, Manni A, Arafah BM.
    Cancer Res; 1982 Aug 19; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [Abstract] [Full Text] [Related]

  • 14. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
    Garcia-Giralt E, Omodei Zorini C, Ferri L, Ayme Y, Carton M, Daban A, Delozier T, Fargeot P, Fumoleau P, Gorins A.
    Clin Ter; 1994 Aug 19; 145(8):113-21. PubMed ID: 7955956
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A, Harvey HA, Santen RJ, Boucher A, White D, Bernath A, Dixon R, Richards G, Shafik A.
    Cancer Res; 1982 Aug 19; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [Abstract] [Full Text] [Related]

  • 16. [The use of aminoglutethimide in the treatment of metastatic breast cancer].
    Bellora MG, Ciancio A, Ferrero A, Bergamino T, Zola P, Sismondi P.
    Minerva Ginecol; 1991 Dec 19; 43(12):589-93. PubMed ID: 1819778
    [Abstract] [Full Text] [Related]

  • 17. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
    Höffken K, Kempf H, Miller AA, Miller B, Schmidt CG, Faber P, Kley HK.
    Cancer Treat Rep; 1986 Oct 19; 70(10):1153-7. PubMed ID: 3756937
    [Abstract] [Full Text] [Related]

  • 18. [Aminoglutethimide therapy in advanced breast cancer].
    Kühböck J, Ludwig H, Pötzi P, Zielinski C.
    Wien Med Wochenschr; 1985 Dec 31; 135(23-24):608-11. PubMed ID: 4096007
    [Abstract] [Full Text] [Related]

  • 19. Medical adrenalectomy with aminoglutethimide-cortisol in the treatment of metastatic breast carcinoma.
    Paridaens R, Van Haelen C, Heuson JC.
    Eur J Cancer (1965); 1980 Dec 31; Suppl 1():103-6. PubMed ID: 7318860
    [No Abstract] [Full Text] [Related]

  • 20. [Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day].
    Bonneterre J, Coppens H, Mauriac L, Rouesse J, Fargeot P, Metz R, Armand JP, Mathieu A, Tubiana M, Cappelaere P.
    Acta Clin Belg Suppl; 1986 Dec 31; 11():41-8. PubMed ID: 3521171
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.